News
Nurse practitioners should listen to patients’ concerns and be ready with questions when it comes to germline testing, according to an expert.
Tara Sweeney, BSN, RN, OCN, CHPN discussed best care for the health and well-being of a person across all stages of their cancer survivorship.
The FDA has granted approval to nivolumab plus ipilimumab for use in unresectable or metastatic hepatocellular carcinoma.
In accordance with CMS quality measures, interventions like provider/patient education and better access to care help reduce ...
Oncology nurses and APPs can enhance patients’ comfort by counseling patients on what integrative care is and working to make those options accessible.
Panelists discuss how the new FDA-approved formulation of nilotinib offers significant advantages over the original version by eliminating fasting requirements, potentially improving patient adherence ...
Panelists discuss how chronic myeloid leukemia (CML) treatment has evolved over the past 5 years, highlighting advancements in tyrosine kinase inhibitor (TKI) therapy, improved adverse effect ...
Using risk assessment and nurse education in the High ED/Admission Risk Therapy (HEART) protocol reduced ED visits by 18% ...
Extraordinary Healer® Award was presented during the 50th Annual Oncology Nursing Society Congress, recognizing oncology ...
Using liquid biopsies to test for ESR1 mutations in breast cancer is more feasible for patients and has quicker turnaround ...
Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...
Practicing at top of licensure can create opportunities for oncology APPs to engage with patients and other providers in new ways.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results